LAMEA Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile based Applications, Sensors, and Other Type), By Clinical Practice, By End Use, By Country and Growth Forecast, 2024 - 2031

The Latin America, Middle East and Africa Psychiatric Digital Biomarkers Market would witness market growth of 26.4% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Psychiatric Digital Biomarkers Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $50 million by 2031. The Argentina market is expected to witness a CAGR of 27.4% during (2024 - 2031). Additionally, The UAE market is expected to witness a CAGR of 25.3% during (2024 - 2031).

Virtual care platforms and wearable devices further enhance the integration of psychiatric digital biomarkers. Telehealth services use data from wearables, such as physiological metrics and behavioral patterns, to support remote mental health monitoring and informed treatment decisions. Wearables provide real-time insights into mental health conditions, allowing for proactive interventions. Together, these components of the digital health ecosystem create a robust framework for improving mental health care, making it more inclusive, precise, and accessible for diverse populations.

The growing aging population is significantly impacting the prevalence of age-related psychiatric conditions, necessitating the development of innovative diagnostic tools and solutions. As life expectancy increases worldwide, so does the number of older adults, many of whom are at heightened risk for mental health disorders, including dementia, depression, and anxiety.

In South America, the Pan American Health Organization (PAHO) highlights the profound impact of mental, neurological, substance use disorders, and suicide (MNSS) in Brazil. These conditions account for 19% of all disability-adjusted life years (DALYs) and 38% of all years lived with disability (YLDs) in the country. Mental and behavioral problems are the third leading cause of sick leave, comprising 52% of all social benefits disbursed between 2007 and 2017. Mood disorders alone represent around half of these claims. As of October 2020, an estimated 65,453 employees were on temporary leave due to mental illness, constituting approximately 8% of all paid sick leave benefits. Additionally, 284,292 Brazilians are retired due to mental health conditions, reflecting the long-term socioeconomic impact of these disorders. Therefore, these challenges underscore the urgent need for innovative psychiatric digital biomarkers to facilitate early detection, monitoring, and intervention for mental health conditions in the LAMEA region.

Free Valuable Insights: The Worldwide Psychiatric Digital Biomarkers Market is Projected to reach USD 2.78 Billion by 2031, at a CAGR of 24.1%

Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors, and Other Type. Based on Clinical Practice, the market is segmented into Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers, and Other Clinical Practice. Based on End Use, the market is segmented into Healthcare Companies, Healthcare Providers, Payers, and Other End Use. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Canary Speech, Inc
• Sonde Health, Inc. (Puretech Health Plc)
• Koneksa Health Inc.
• Empatica Inc.
• VivoSense, Inc.
• IXICO Plc
• Neurotrack Technologies, Inc.
• Winterlight Labs
• Aural Analytics, Inc. (Linus Health)

LAMEA Psychiatric Digital Biomarkers Market Report Segmentation

By Type

• Wearable
• Mobile based Applications
• Sensors
• Other Type

By Clinical Practice

• Diagnostic Psychiatric Digital Biomarkers
• Monitoring Psychiatric Digital Biomarkers
• Predictive and Prognostic Psychiatric Digital Biomarkers
• Other Clinical Practice

By End Use

• Healthcare Companies
• Healthcare Providers
• Payers
• Other End Use

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Psychiatric Digital Biomarkers Market, by Type
1.4.2 LAMEA Psychiatric Digital Biomarkers Market, by Clinical Practice
1.4.3 LAMEA Psychiatric Digital Biomarkers Market, by End Use
1.4.4 LAMEA Psychiatric Digital Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Psychiatric Digital Biomarkers Market by Type
4.1 LAMEA Wearable Market by Country
4.2 LAMEA Mobile based Applications Market by Country
4.3 LAMEA Sensors Market by Country
4.4 LAMEA Other Type Market by Country

Chapter 5. LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice
5.1 LAMEA Diagnostic Psychiatric Digital Biomarkers Market by Country
5.2 LAMEA Monitoring Psychiatric Digital Biomarkers Market by Country
5.3 LAMEA Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country
5.4 LAMEA Other Clinical Practice Market by Country

Chapter 6. LAMEA Psychiatric Digital Biomarkers Market by End Use
6.1 LAMEA Healthcare Companies Market by Country
6.2 LAMEA Healthcare Providers Market by Country
6.3 LAMEA Payers Market by Country
6.4 LAMEA Other End Use Market by Country

Chapter 7. LAMEA Psychiatric Digital Biomarkers Market by Country
7.1 Brazil Psychiatric Digital Biomarkers Market
7.1.1 Brazil Psychiatric Digital Biomarkers Market by Type
7.1.2 Brazil Psychiatric Digital Biomarkers Market by Clinical Practice
7.1.3 Brazil Psychiatric Digital Biomarkers Market by End Use
7.2 Argentina Psychiatric Digital Biomarkers Market
7.2.1 Argentina Psychiatric Digital Biomarkers Market by Type
7.2.2 Argentina Psychiatric Digital Biomarkers Market by Clinical Practice
7.2.3 Argentina Psychiatric Digital Biomarkers Market by End Use
7.3 UAE Psychiatric Digital Biomarkers Market
7.3.1 UAE Psychiatric Digital Biomarkers Market by Type
7.3.2 UAE Psychiatric Digital Biomarkers Market by Clinical Practice
7.3.3 UAE Psychiatric Digital Biomarkers Market by End Use
7.4 Saudi Arabia Psychiatric Digital Biomarkers Market
7.4.1 Saudi Arabia Psychiatric Digital Biomarkers Market by Type
7.4.2 Saudi Arabia Psychiatric Digital Biomarkers Market by Clinical Practice
7.4.3 Saudi Arabia Psychiatric Digital Biomarkers Market by End Use
7.5 South Africa Psychiatric Digital Biomarkers Market
7.5.1 South Africa Psychiatric Digital Biomarkers Market by Type
7.5.2 South Africa Psychiatric Digital Biomarkers Market by Clinical Practice
7.5.3 South Africa Psychiatric Digital Biomarkers Market by End Use
7.6 Nigeria Psychiatric Digital Biomarkers Market
7.6.1 Nigeria Psychiatric Digital Biomarkers Market by Type
7.6.2 Nigeria Psychiatric Digital Biomarkers Market by Clinical Practice
7.6.3 Nigeria Psychiatric Digital Biomarkers Market by End Use
7.7 Rest of LAMEA Psychiatric Digital Biomarkers Market
7.7.1 Rest of LAMEA Psychiatric Digital Biomarkers Market by Type
7.7.2 Rest of LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice
7.7.3 Rest of LAMEA Psychiatric Digital Biomarkers Market by End Use

Chapter 8. Company Profiles
8.1 Canary Speech, Inc.
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Sonde Health, Inc. (Puretech Health Plc)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.2.5 SWOT Analysis
8.3 Koneksa Health Inc.
8.3.1 Company Overview
8.4 Empatica Inc.
8.4.1 Company Overview
8.5 VivoSense, Inc.
8.5.1 Company Overview
8.6 IXICO plc
8.6.1 Company Overview
8.7 Neurotrack Technologies, Inc.
8.7.1 Company Overview
8.8 WinterLight Labs
8.8.1 Company Overview
8.9 Aural Analytics, Inc. (Linus Health)
8.9.1 Company Overview

TABLE 1 LAMEA Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 4 LAMEA Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 5 LAMEA Wearable Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Wearable Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Mobile based Applications Market by Country, 2020 - 2023, USD Million
TABLE 8 LAMEA Mobile based Applications Market by Country, 2024 - 2031, USD Million
TABLE 9 LAMEA Sensors Market by Country, 2020 - 2023, USD Million
TABLE 10 LAMEA Sensors Market by Country, 2024 - 2031, USD Million
TABLE 11 LAMEA Other Type Market by Country, 2020 - 2023, USD Million
TABLE 12 LAMEA Other Type Market by Country, 2024 - 2031, USD Million
TABLE 13 LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 14 LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 15 LAMEA Diagnostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Diagnostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Monitoring Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Monitoring Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 19 LAMEA Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 20 LAMEA Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 21 LAMEA Other Clinical Practice Market by Country, 2020 - 2023, USD Million
TABLE 22 LAMEA Other Clinical Practice Market by Country, 2024 - 2031, USD Million
TABLE 23 LAMEA Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 24 LAMEA Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 25 LAMEA Healthcare Companies Market by Country, 2020 - 2023, USD Million
TABLE 26 LAMEA Healthcare Companies Market by Country, 2024 - 2031, USD Million
TABLE 27 LAMEA Healthcare Providers Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA Healthcare Providers Market by Country, 2024 - 2031, USD Million
TABLE 29 LAMEA Payers Market by Country, 2020 - 2023, USD Million
TABLE 30 LAMEA Payers Market by Country, 2024 - 2031, USD Million
TABLE 31 LAMEA Other End Use Market by Country, 2020 - 2023, USD Million
TABLE 32 LAMEA Other End Use Market by Country, 2024 - 2031, USD Million
TABLE 33 LAMEA Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 34 LAMEA Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 35 Brazil Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 36 Brazil Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 37 Brazil Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 38 Brazil Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 39 Brazil Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 40 Brazil Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 41 Brazil Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 42 Brazil Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 43 Argentina Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 44 Argentina Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 45 Argentina Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 46 Argentina Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 47 Argentina Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 48 Argentina Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 49 Argentina Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 50 Argentina Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 51 UAE Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 52 UAE Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 53 UAE Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 54 UAE Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 55 UAE Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 56 UAE Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 57 UAE Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 58 UAE Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 59 Saudi Arabia Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 60 Saudi Arabia Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 61 Saudi Arabia Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 62 Saudi Arabia Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 63 Saudi Arabia Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 64 Saudi Arabia Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 65 Saudi Arabia Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 66 Saudi Arabia Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 67 South Africa Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 68 South Africa Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 69 South Africa Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 70 South Africa Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 71 South Africa Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 72 South Africa Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 73 South Africa Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 74 South Africa Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 75 Nigeria Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 76 Nigeria Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 77 Nigeria Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 78 Nigeria Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 79 Nigeria Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 80 Nigeria Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 81 Nigeria Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 82 Nigeria Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 83 Rest of LAMEA Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
TABLE 84 Rest of LAMEA Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
TABLE 85 Rest of LAMEA Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
TABLE 86 Rest of LAMEA Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
TABLE 87 Rest of LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
TABLE 88 Rest of LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
TABLE 89 Rest of LAMEA Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
TABLE 90 Rest of LAMEA Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
TABLE 91 Key Information – Canary Speech, Inc.
TABLE 92 Key Information – Sonde Health, Inc.
TABLE 93 Key Information – Koneksa Health Inc.
TABLE 94 Key Information – Empatica Inc.
TABLE 95 Key Information – VivoSense, Inc.
TABLE 96 Key Information – IXICO plc
TABLE 97 Key Information – Neurotrack Technologies, Inc.
TABLE 98 Key Information – WinterLight Labs
TABLE 99 Key Information – Aural Analytics, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Psychiatric Digital Biomarkers Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Psychiatric Digital Biomarkers Market
FIG 4 Porter’s Five Forces Analysis – Psychiatric Digital Biomarkers Market
FIG 5 LAMEA Psychiatric Digital Biomarkers Market share by Type, 2023
FIG 6 LAMEA Psychiatric Digital Biomarkers Market share by Type, 2031
FIG 7 LAMEA Psychiatric Digital Biomarkers Market by Type, 2020 - 2031, USD Million
FIG 8 LAMEA Psychiatric Digital Biomarkers Market share by Clinical Practice, 2023
FIG 9 LAMEA Psychiatric Digital Biomarkers Market share by Clinical Practice, 2031
FIG 10 LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2031, USD Million
FIG 11 LAMEA Psychiatric Digital Biomarkers Market share by End Use, 2023
FIG 12 LAMEA Psychiatric Digital Biomarkers Market share by End Use, 2031
FIG 13 LAMEA Psychiatric Digital Biomarkers Market by End Use, 2020 - 2031, USD Million
FIG 14 LAMEA Psychiatric Digital Biomarkers Market share by Country, 2023
FIG 15 LAMEA Psychiatric Digital Biomarkers Market share by Country, 2031
FIG 16 LAMEA Psychiatric Digital Biomarkers Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Canary Speech, Inc.
FIG 18 Recent strategies and developments: Sonde Health, Inc.
FIG 19 SWOT Analysis: Sonde Health, Inc.